A recent study reveals that individuals who stop using new slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt conventional diet and exercise programs.
Published data in a major medical journal demonstrates that while obese individuals frequently drop substantial amounts of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users buying these treatments need to be informed of the potential of rapid weight regain when the therapy concludes," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to starting mass within about one and a half years.
Weighing Approaches
The study, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.
Scientists point out that individuals who lose weight through dieting typically experience a slower creep back—approximately 100 grams monthly—once they finish.
Understanding the Quick Regain
Nutrition scientists believe the way of the injections accounts for the amplified rebound.
GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication means appetite is unsuppressed, making binge eating much more probable."
A Lifelong Condition?
Health authorities advise the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians say that, due to the likelihood of relapse, the treatment is often long-term.
This view is reinforced by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," comparing it to managing conditions like hypertension.
User Accounts
Users who have stopped the medication describe a powerful resurgence of hunger.
"I experienced a switch activating and you're instantly extremely hungry," described a patient.
This difficulty is exacerbated if users have not developed lasting lifestyle or habit changes during treatment.
Widespread Adoption
Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is higher among females than males.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
Finally, experts emphasize that while the jabs are effective tools for weight loss, they are not a standalone solution and lasting health benefits relies on integrated lifestyle management.
